News

Obituary Notice: Professor Shigetaka Asano

The Japan Society of Gene and Cell Therapy (JSGCT) has announced that Professor Shigetaka Asano, the first president of JSGCT, passed away on 12th August 2020.

We extend our thoughts and best wishes to all at JSGCT.

Heading

Previous Next

ACCOUNT LOGIN

Forgotten password? Not a member? CREATE ACCOUNT

OUR SPONSORS

GOLD

SILVER

SUPPORTER

View all

View on Facebook

Tweets by ESGCT

View on Twitter

Non-viral genetic therapy strategies for the treatment of ataxia telangiectasia

James Grey received the ESGCT-sponsored prize for best poster presentation at the British Society for Gene and Cell Therapy (BSGCT) Annual Conference, which took place from 19-21 June 2019. Read about his winning presentation here!

Gene therapy for thrombotic thrombocytopaenic purpura

Robyn Bell received the ESGCT-sponsored prize for best oral presentation at the British Society for Gene and Cell Therapy (BSGCT) Annual Conference, which took place from 19-21 June 2019. Read about her winning presentation here!

CRISPR-Cas9 genome editing - molecular scissors a bit too sharp?

Grégoire Cullot received the ESGCT-sponsored prize for best oral presentation at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about his winning presentation here!

Dgkk as a new therapeutic target in the Fmr1-KO murine model of Fragile X

Karima Habbas received the ESGCT-sponsored prize for best poster at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about her winning presentation here!

View on Blog

News

Obituary Notice: Professor Shigetaka Asano

Home

Cookies

Privacy Policy

Terms and Conditions abstract submission

Terms and Conditions congress registration

Terms and Conditions membership purchase

Terms and Conditions user account